Zhang Chenchen, Zhao Jing, Zhu Zhe, Li Yanxia, Li Ke, Wang Yuanping, Zheng Yajuan
Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, China.
Front Med (Lausanne). 2022 Mar 11;9:840498. doi: 10.3389/fmed.2022.840498. eCollection 2022.
With the continuous development of computer technology, big data acquisition and imaging methods, the application of artificial intelligence (AI) in medical fields is expanding. The use of machine learning and deep learning in the diagnosis and treatment of ophthalmic diseases is becoming more widespread. As one of the main causes of visual impairment, myopia has a high global prevalence. Early screening or diagnosis of myopia, combined with other effective therapeutic interventions, is very important to maintain a patient's visual function and quality of life. Through the training of fundus photography, optical coherence tomography, and slit lamp images and through platforms provided by telemedicine, AI shows great application potential in the detection, diagnosis, progression prediction and treatment of myopia. In addition, AI models and wearable devices based on other forms of data also perform well in the behavioral intervention of myopia patients. Admittedly, there are still some challenges in the practical application of AI in myopia, such as the standardization of datasets; acceptance attitudes of users; and ethical, legal and regulatory issues. This paper reviews the clinical application status, potential challenges and future directions of AI in myopia and proposes that the establishment of an AI-integrated telemedicine platform will be a new direction for myopia management in the post-COVID-19 period.
随着计算机技术、大数据采集与成像方法的不断发展,人工智能(AI)在医学领域的应用正在不断拓展。机器学习和深度学习在眼科疾病诊治中的应用日益广泛。近视作为视力损害的主要原因之一,在全球具有很高的患病率。近视的早期筛查或诊断,结合其他有效的治疗干预措施,对于维持患者的视觉功能和生活质量非常重要。通过眼底摄影、光学相干断层扫描和裂隙灯图像的训练,以及借助远程医疗提供的平台,AI在近视的检测、诊断、进展预测和治疗方面展现出巨大的应用潜力。此外,基于其他形式数据的AI模型和可穿戴设备在近视患者的行为干预方面也表现出色。诚然,AI在近视实际应用中仍存在一些挑战,如数据集的标准化、用户的接受态度以及伦理、法律和监管问题。本文综述了AI在近视方面的临床应用现状、潜在挑战和未来方向,并提出建立整合AI的远程医疗平台将是新冠疫情后近视管理的新方向。